Study Summary
This trial will test a new, non-invasive therapy that could improve Parkinson's Disease symptoms. It could be the first step towards a medication-free treatment.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 2 Secondary · Reporting Duration: Change from Baseline at 2 weeks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Low Intensity Focused Ultrasound
1 of 2
Control
1 of 2
Experimental Treatment
Non-Treatment Group
30 Total Participants · 2 Treatment Groups
Primary Treatment: Low Intensity Focused Ultrasound · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are individuals being accepted into this research study at present?
"Checking the clinicaltrials.gov listing, it appears that this study is still recruiting participants; posted on June 15th 2022 and last modified March 13th 2023." - Anonymous Online Contributor
Is eligibility for this experiment limited to those over 18 years of age?
"According to the requirements outlined in the trial protocols, individuals must be of legal age (minimum 18) and under 65 years old to participate." - Anonymous Online Contributor
Who is qualified to participate in this experiment?
"This clinical trial seeks 30 participants with a Parkinson's Disease diagnosis and of age 18-65. Eligibility criteria is strictly limited to those conditions." - Anonymous Online Contributor
How many volunteers have signed up for the trial thus far?
"Affirmative. Per the information published on clinicaltrials.gov, this investigation is actively seeking subjects for participation. It was posted to the website on June 15th 2022 and last updated March 13th 2023; 30 participants are needed from a single site." - Anonymous Online Contributor